Product class:
|
Medicinal product with marketing authorization
|
Medicinal product class:
|
Veterinary medicine
|
Name of medicinal product:
|
Imrestor
|
Active substances:
|
|
ATC code:
|
QL03AA90
|
Dosage form:
|
solution for injection
|
Strength:
|
15mg 2.7ml
|
Legal status for supply*:
|
Subject to medicinal prescription
|
Summary of product characteristics (SPC):
|
|
Package information leaflet (PIL):
|
EST
|
Labelling:
|
|
Indication:
|
As an aid in a herd management programme, to reduce the risk of clinical mastitis in periparturient
dairy cows and heifers during the 30 days following calving.
|
Safety features:
|
No
|
Marketing authorization holder:
|
Elanco GmbH
|
Marketing authorization number:
|
EU/2/15/193
|
Marketing authorization issued on:
|
December 9, 2015
|
Marketing authorization expires on:
|
Unlimited
|
Marketing authorization procedure type:
|
Centralised
|
Assessment report:
|
|
Package code
|
Name of medicinal product
|
Dosage form
|
Package
|
Legal status
|
Reimbursements
|
Reference price
|
Last imported
|
PƤritolumaa
|
Additional information
|
1706150
|
Imrestor
|
solution for injection
|
15mg 2.7ml 2.7ml 10TK
|
Prescription
|
|
|
26.11.2018
|
|
|
1706161
|
Imrestor
|
solution for injection
|
15mg 2.7ml 2.7ml 50TK
|
Prescription
|
|
|
|
|
|
1706172
|
Imrestor
|
solution for injection
|
15mg 2.7ml 2.7ml 100TK
|
Prescription
|
|
|
|
|
|
Legal status for supply – medicinal product on medical prescription or not subject to medical prescription
You can download Acrobat Reader fromhere